Chloramphenicol acetyltransferase as a selection marker for chlamydial transformation

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Xu, Shuang ^a   Battaglia, Lauren ^a,b   Bao, Xiaofeng ^a,c   Fan, Huizhou ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NANTONG MEDICAL COLLEGE   (China)

Author keywords

Chlamydia; Chlamydia trachomatis; Chloramphenicol; Chloramphenicol acetyltransferase; Sexually transmitted infections; Transformation; Transformation selection marker

Indexed keywords

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIAE;

CHLORAMPHENICOL ACETYLTRANSFERASE; GLYCOGEN; GREEN FLUORESCENT PROTEIN;

ARTICLE; BIOSYNTHESIS; CHLAMYDIA TRACHOMATIS; ENZYMOLOGY; FEMALE; GENETIC MARKER; GENETIC TRANSFORMATION; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; PLASMID; PREGNANCY;

CHLAMYDIA TRACHOMATIS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; FEMALE; GENETIC MARKERS; GLYCOGEN; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; PLASMIDS; PREGNANCY; TRANSFORMATION, GENETIC;

EID: 84884388571     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-377     Document Type: Article

References (21)

1. Infection and disease epidemiology. Schachter J, Chlamydia Intracellular Biology, Pathogenesis Washington DC: ASM Press, Stephens RS, 1999 139 169
2. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Campbell LA, Kuo CC, Nat Rev Microbiol 2004 2 1 23 32 10.1038/nrmicro796 15035006 (Pubitemid 39490045)
3. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP, Med Microbiol Immunol (Berl) 1998 187 1 23 42 10.1007/s004300050071 (Pubitemid 28383127)
4. Chlamydia pneumoniae and cardiovascular disease. Campbell LA, Kuo CC, Grayston JT, Emerg Infect Dis 1998 4 4 571 579 10.3201/eid0404.980407 9866733 (Pubitemid 28553681)
5. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. Hu H, Pierce GN, Zhong G, J Clin Invest 1999 103 5 747 753 10.1172/JCI4582 10074493 (Pubitemid 29122429)
6. Chlamydia vaccines: recent developments and the role of adjuvants in future formulations. Igietseme JU, Eko FO, Black CM, Expert Rev Vaccines 2011 10 11 1585 1596 10.1586/erv.11.139 22043957
7. Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Rockey DD, Wang J, Lei L, Zhong G, Expert Rev Vaccines 2009 8 10 1365 1377 10.1586/erv.09.98 19803759
8. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Clarke IN, PLoS Pathog 2011 7 9 1002258 10.1371/journal.ppat.1002258 21966270
9. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Song L, Carlson JH, Whitmire WM, Kari L, Virtaneva K, Sturdevant DE, Watkins H, Zhou B, Sturdevant GL, Porcella SF, et al. Infect Immun 2013 81 3 636 644 10.1128/IAI.01305-12 23319558
10. Characterization of Chlamydia trachomatis plasmid-encoded open reading frames. Gong S, Yang Z, Lei L, Shen L, Zhong G, J Bacteriol 2013 195 17 3819 3826 10.1128/JB.00511-13 23794619
11. Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Gerard HC, Mishra MK, Mao G, Wang S, Hali M, Whittum-Hudson JA, Kannan RM, Hudson AP, Nanomedicine 2013 S1549-9634 13 00176 00177
12. The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Peterson EM, Markoff BA, Schachter J, De la Maza LM, Plasmid 1990 23 2 144 148 10.1016/0147-619X(90)90033-9 2362949 (Pubitemid 20202913)
13. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Caldwell HD, Kromhout J, Schachter J, Infect Immun 1981 31 3 1161 1176 7228399 (Pubitemid 11155484)
14. Chlamydia trachomatis protein GrgA activates transcription by contacting the nonconserved region of σ66. Bao X, Nickels BE, Fan H, Proc Natl Acad Sci 2012 109 42 16870 16875 10.1073/pnas.1207300109 23027952
15. Productive Chlamydia trachomatis lymphogranuloma venereum 434 infection in cells with augmented or inactivated autophagic activities. Pachikara N, Zhang H, Pan Z, Jin S, Fan H, FEMS Microbiol Lett 2009 292 2 240 249 10.1111/j.1574-6968.2009.01494.x 19187200
16. Regulation of chlamydial infection by host autophagy and vacuolar ATPase-bearing organelles. Yasir M, Pachikara ND, Bao X, Pan Z, Fan H, Infect Immun 2011 79 10 4019 4028 10.1128/IAI.05308-11 21807906
17. Chloramphenicol causes mitochondrial stress, decreases ATP biosynthesis, induces matrix metalloproteinase-13 expression, and solid-tumor cell invasion. Li C-H, Cheng Y-W, Liao P-L, Yang Y-T, Kang J-J, Toxicol Sci 2010 116 1 140 150 10.1093/toxsci/kfq085 20338993
18. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Suchland RJ, Geisler WM, Stamm WE, Antimicrob Agents Chemother 2003 47 2 636 642 10.1128/AAC.47.2.636-642.2003 12543671 (Pubitemid 36158094)
19. Genetic transformation of a clinical (genital tract), plasmid-free isolate of Chlamydia trachomatis: engineering the plasmid as a cloning vector. Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Persson K, Bjartling C, Clarke IN, PLoS One 2013 8 3 59195 10.1371/journal.pone.0059195 23527131
20. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Carlson JH, Whitmire WM, Crane DD, Wicke L, Virtaneva K, Sturdevant DE, Kupko JJ 3rd, Porcella SF, Martinez-Orengo N, Heinzen RA, et al. Infect Immun 2008 76 6 2273 2283 10.1128/IAI.00102-08 18347045
21. Expression of recombinant DNA introduced into Chlamydia trachomatis by electroporation. Tam JE, Davis CH, Wyrick PB, Can J Microbiol 1994 40 7 583 591 10.1139/m94-093 8076253 (Pubitemid 24251554)